PARP vs PARG: exploring poly (ADP-ribose) glycohydrolase inhibitors in the context of high-grade serous ovarian cancer.
Authors
Taylor, Stephen STighe, Anthony
Pillay, Nisha
Bah, Nourdine
Nelson, Louisa
James, Dominic I
Clamp, Andrew R
Edmondson, Richard
Jayson, Gordon C
Affiliation
Manchester Cancer Research Centre, ManchesterIssue Date
2018-08-01
Metadata
Show full item recordCitation
PARP vs PARG: exploring poly (ADP-ribose) glycohydrolase inhibitors in the context of high-grade serous ovarian cancer. 2018, 24(15_Suppl): 78-78 Clin Cancer ResJournal
Clinical Cancer ResearchDOI
10.1158/1557-3265.OVCA17-A72Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1158/1557-3265.OVCA17-A72